Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam meal-test study for post-bypass hypoglycemia after cholecystectomy
NL-OMON28329Not yet recruiting
- Sponsor
- Medisch Centrum Leeuwarden
- Start
- Nov 2021
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of colesevelam in Postprandial hyperinsulinemic hypoglycemia (PHH) (2 arms), sponsored by Medisch Centrum Leeuwarden. Primary endpoint: Glucose nadir during mixed meal test. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
colesevelam
03
Conditions
Postprandial hyperinsulinemic hypoglycemia (PHH)
Beyond the preview
Go deeper on NL-OMON28329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28329.